You are the owner of this page.
Edit Page
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Direxion S&P Biotech Bull 3X (NY: LABU)
47.37 USD  +1.17 (+2.53%)
Official Closing Price  /  Updated: 7:59 PM EDT, Jun 5, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Direxion S&P Biotech Bull 3X
Sector
Exchange Traded NY
Net Assets 204.24M
Inception Date
Related Funds
Quote
Price 47.37
Volume 2,570,400
Last Trade Jun 05, 7:59pm
Change (%)
+1.17 (2.53%)
Prev. Close 46.20
YTD %
-16.09%
Dividend Yield 0.24%
Performance
YTD
-9.08 (-16.09%)
1 Month
+5.28 (12.54%)
3 Month
+1.40 (3.05%)
6 Month
-9.07 (-16.07%)
1 Year
+6.57 (16.10%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Leveraged ETFs That Have Gained More Than 80% at Halfway Q2
Here are some leveraged equity ETFs that piled up more than 80% returns halfway through the second quarter. These funds will continue to be investors’ darlings provided the sentiments remain bullish. Read More
from Blogs - TalkMarkets
Traders Can Look to Biotech ETFs to For a Potential Virus Cure
The vaccine rally could be in its early stages of Monday’s trading session is an early indication after the Dow Jones Industrial Average posted a 900-point rise to mark its best day since early April.... Read More
from ETF Trends
Top News
More News
In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs
Following months of mounting infection rates and rising economic uncertainty, the world is beginning to see brief glimmers of hope from ... Read More
from Benzinga
LABU Crosses Above Key Moving Average Level
In trading on Monday, shares of the Daily S&P Biotech Bull 3X Shares ETF (LABU) crossed above their 200 day moving average of $42.54, changing hands as high as $44.03 per share. Daily S&P Biotech Bull... Read More
from ETF Channel
Interesting LABU Put And Call Options For May 15th
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options become available this week, for the May 15th expiration. At Stock Options... Read More
from Market News Video
SH, LABU: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the ProShares Short S&P500, which added 15,725,000 units, or a 17.8%... Read More
from ETF Channel
3 Leveraged Healthcare ETFs Soaring This Month
Here are some geared healthcare ETFs that are enjoying fabulous February and may have more in store over the next couple of weeks. Read More
from Blogs - TalkMarkets
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory ... Read More
from Benzinga
Buy on the Dip Prospects: January 29 Edition
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in... Read More
from ETFdb
LABU February 28th Options Begin Trading
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options begin trading today, for the February 28th expiration. At Stock Options... Read More
from Market News Video
February 2020 Options Now Available For Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU)
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options begin trading today, for the February 2020 expiration. At Stock Options... Read More
from Market News Video
Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend
The biotech and healthcare space has been on fire lately. The healthcare space is witnessing a Mergers and Acquisitions wave recently that has achieved an impressive $342 billion in new deal activity... Read More
from ETF Trends
Rally Continues Heading Into Shorten Post-Thanksgiving Session
Volume has not gone gangbusters, but given we are in a holiday week it really is no surprise turnover is light. Read More
from Blogs - TalkMarkets
UGAZ: Time To Buy?
Is it time to buy natural gas ETF UGAZ? Read More
from Blogs - TalkMarkets
Sell on the Pop Prospects: November 13 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.